Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
Chi Yan(Vanderbilt University), Anna E. Vilgelm(The Ohio State University), Gregory D. Ayers(Vanderbilt University), Caroline A. Nebhan(VA Tennessee Valley Healthcare System), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Nabil Saleh(Ain Shams University), Rebecca L. Shattuck-Brandt(Vanderbilt University), Vivian Weiß(Vanderbilt University Medical Center), Ann Richmond(Monroe Carell Jr. Children's Hospital)
Cited by 11
Related Papers
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|580
DC isoketal-modified proteins activate T cells and promote hypertension
|Journal of Clinical Investigation|2014|533
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364